-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Chronic Obstructive Pulmonary Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Secukinumab in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Secukinumab in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Secukinumab in Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Secukinumab in Polymyalgia Rheumatica (PMR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Secukinumab in Polymyalgia Rheumatica (PMR) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Secukinumab in Polymyalgia Rheumatica (PMR) Drug Details: Secukinumab (Cosentyx, Zafrez,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Onabotulinumtoxin A in Myofascial Pain Syndrome (Chronic Myofascial Pain)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Onabotulinumtoxin A in Myofascial Pain Syndrome (Chronic Myofascial Pain) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Onabotulinumtoxin A in Myofascial Pain Syndrome...
-
Product Insights
NewTissue Heart Valves Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Tissue Heart Valves Pipeline Market Report Overview Tissue Heart Valves are a combination of tissue and synthetic biomaterials with the tissue itself being flexible. Bovine and porcine valves are included here. The Tissue Heart Valves pipeline market report provides key information and data related to extensive coverage of the Tissue Heart Valves under development. The report provides review details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INB-400 in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INB-400 in Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INB-400 in Glioblastoma Multiforme (GBM) Drug Details: INB-400 is under...
-
Sector Analysis
Pasta and Noodles Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Pasta and Noodles Market Report Overview The pasta and noodles market size was estimated at $89.2 billion in 2022 and is likely to grow at a CAGR of more than 3% from 2022 to 2027. The rising health & wellness (H&W) trend among consumers, busy lifestyles, and rapid urbanization will boost the demand for convenient and easy-to-cook pasta & noodles. Pasta and Noodles Market Outlook 2022-2027 ($ Billion) Buy the Full Report for Pasta and Noodles Market Forecasts Download a...
-
Sector Analysis
Soups Market Opportunities, Trends, Growth Analysis and Forecast to 2027
Soup Market Report Overview The soup market size was estimated at $22.3 billion in 2022 and is likely to grow at a CAGR of more than 4% from 2022 to 2027. The rise in consumers’ purchasing power and investments by leading manufacturers in capacity expansion will enable the sector’s growth in the future. Soup Market Outlook 2022-2027 ($ Billion) Buy the Full Report for Soup Market Forecasts Download a Free Sample Report The soup market research report covers a comprehensive...
-
Product Insights
Fragile X Syndrome – Drugs In Development, 2023
Global Markets Direct’s, ‘Fragile X Syndrome - Drugs In Development, 2023’, provides an overview of the Fragile X Syndrome pipeline landscape. The report provides comprehensive information on the therapeutics under development for Fragile X Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...